Loading clinical trials...
Loading clinical trials...
Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Conditions
Interventions
NanoPac®
Locations
4
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Parkview Cancer Institute
Fort Wayne, Indiana, United States
Texas Tech University Health Sciences Center
El Paso, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
December 1, 2017
Primary Completion Date
March 15, 2023
Completion Date
March 15, 2023
Last Updated
June 24, 2024
NCT06998940
NCT06381154
NCT05825066
NCT05679674
NCT07241663
NCT04665947
Lead Sponsor
NanOlogy, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions